nodes	percent_of_prediction	percent_of_DWPC	metapath
Triflupromazine—DRD1—Parkinson's disease	0.403	0.485	CbGaD
Triflupromazine—DRD2—Parkinson's disease	0.284	0.342	CbGaD
Triflupromazine—ABCB1—Parkinson's disease	0.144	0.173	CbGaD
Triflupromazine—DRD1—telencephalic ventricle—Parkinson's disease	0.00555	0.114	CbGeAlD
Triflupromazine—DRD1—nerve—Parkinson's disease	0.0035	0.0718	CbGeAlD
Triflupromazine—DRD2—telencephalic ventricle—Parkinson's disease	0.00328	0.0673	CbGeAlD
Triflupromazine—DRD2—nerve—Parkinson's disease	0.00207	0.0424	CbGeAlD
Triflupromazine—DRD2—hindbrain—Parkinson's disease	0.00155	0.0318	CbGeAlD
Triflupromazine—DRD1—brainstem—Parkinson's disease	0.0015	0.0308	CbGeAlD
Triflupromazine—DRD1—forebrain—Parkinson's disease	0.00145	0.0297	CbGeAlD
Triflupromazine—CHRM2—forebrain—Parkinson's disease	0.00117	0.024	CbGeAlD
Triflupromazine—CHRM1—forebrain—Parkinson's disease	0.00106	0.0218	CbGeAlD
Triflupromazine—HTR2B—forebrain—Parkinson's disease	0.00106	0.0217	CbGeAlD
Triflupromazine—CHRM2—cardiovascular system—Parkinson's disease	0.000987	0.0203	CbGeAlD
Triflupromazine—DRD1—midbrain—Parkinson's disease	0.000956	0.0196	CbGeAlD
Triflupromazine—CHRM1—cardiovascular system—Parkinson's disease	0.000898	0.0184	CbGeAlD
Triflupromazine—HTR2B—cardiovascular system—Parkinson's disease	0.000894	0.0183	CbGeAlD
Triflupromazine—DRD2—brainstem—Parkinson's disease	0.000886	0.0182	CbGeAlD
Triflupromazine—DRD2—forebrain—Parkinson's disease	0.000856	0.0176	CbGeAlD
Triflupromazine—DRD1—head—Parkinson's disease	0.000829	0.017	CbGeAlD
Triflupromazine—BCHE—brainstem—Parkinson's disease	0.000804	0.0165	CbGeAlD
Triflupromazine—DRD1—nervous system—Parkinson's disease	0.000786	0.0161	CbGeAlD
Triflupromazine—BCHE—forebrain—Parkinson's disease	0.000776	0.0159	CbGeAlD
Triflupromazine—DRD1—central nervous system—Parkinson's disease	0.000757	0.0155	CbGeAlD
Triflupromazine—CHRM2—head—Parkinson's disease	0.000668	0.0137	CbGeAlD
Triflupromazine—BCHE—cardiovascular system—Parkinson's disease	0.000656	0.0135	CbGeAlD
Triflupromazine—CHRM2—nervous system—Parkinson's disease	0.000634	0.013	CbGeAlD
Triflupromazine—CHRM2—central nervous system—Parkinson's disease	0.00061	0.0125	CbGeAlD
Triflupromazine—CHRM1—head—Parkinson's disease	0.000608	0.0125	CbGeAlD
Triflupromazine—HTR2B—head—Parkinson's disease	0.000605	0.0124	CbGeAlD
Triflupromazine—DRD1—brain—Parkinson's disease	0.000601	0.0123	CbGeAlD
Triflupromazine—CHRM1—nervous system—Parkinson's disease	0.000577	0.0118	CbGeAlD
Triflupromazine—HTR2B—nervous system—Parkinson's disease	0.000574	0.0118	CbGeAlD
Triflupromazine—DRD2—midbrain—Parkinson's disease	0.000565	0.0116	CbGeAlD
Triflupromazine—BCHE—medulla oblongata—Parkinson's disease	0.000561	0.0115	CbGeAlD
Triflupromazine—CHRM1—central nervous system—Parkinson's disease	0.000555	0.0114	CbGeAlD
Triflupromazine—HTR2B—central nervous system—Parkinson's disease	0.000552	0.0113	CbGeAlD
Triflupromazine—BCHE—midbrain—Parkinson's disease	0.000512	0.0105	CbGeAlD
Triflupromazine—BCHE—spinal cord—Parkinson's disease	0.0005	0.0103	CbGeAlD
Triflupromazine—DRD2—head—Parkinson's disease	0.00049	0.0101	CbGeAlD
Triflupromazine—CHRM2—brain—Parkinson's disease	0.000484	0.00994	CbGeAlD
Triflupromazine—DRD2—nervous system—Parkinson's disease	0.000464	0.00954	CbGeAlD
Triflupromazine—DRD2—central nervous system—Parkinson's disease	0.000447	0.00918	CbGeAlD
Triflupromazine—BCHE—head—Parkinson's disease	0.000444	0.00912	CbGeAlD
Triflupromazine—CHRM1—brain—Parkinson's disease	0.000441	0.00905	CbGeAlD
Triflupromazine—HTR2B—brain—Parkinson's disease	0.000438	0.009	CbGeAlD
Triflupromazine—DRD2—cerebellum—Parkinson's disease	0.000437	0.00897	CbGeAlD
Triflupromazine—BCHE—nervous system—Parkinson's disease	0.000421	0.00865	CbGeAlD
Triflupromazine—ABCB1—embryo—Parkinson's disease	0.000418	0.00858	CbGeAlD
Triflupromazine—BCHE—central nervous system—Parkinson's disease	0.000406	0.00833	CbGeAlD
Triflupromazine—BCHE—cerebellum—Parkinson's disease	0.000396	0.00814	CbGeAlD
Triflupromazine—ABCB1—forebrain—Parkinson's disease	0.00037	0.00759	CbGeAlD
Triflupromazine—DRD2—brain—Parkinson's disease	0.000355	0.00729	CbGeAlD
Triflupromazine—BCHE—brain—Parkinson's disease	0.000322	0.00661	CbGeAlD
Triflupromazine—ABCB1—cardiovascular system—Parkinson's disease	0.000313	0.00642	CbGeAlD
Triflupromazine—Acetophenazine—DRD1—Parkinson's disease	0.000278	0.0304	CrCbGaD
Triflupromazine—ABCB1—medulla oblongata—Parkinson's disease	0.000267	0.00549	CbGeAlD
Triflupromazine—Propericiazine—DRD1—Parkinson's disease	0.000245	0.0269	CrCbGaD
Triflupromazine—ABCB1—midbrain—Parkinson's disease	0.000244	0.00501	CbGeAlD
Triflupromazine—ABCB1—spinal cord—Parkinson's disease	0.000238	0.00489	CbGeAlD
Triflupromazine—ABCB1—head—Parkinson's disease	0.000212	0.00435	CbGeAlD
Triflupromazine—ABCB1—nervous system—Parkinson's disease	0.000201	0.00412	CbGeAlD
Triflupromazine—Acetophenazine—DRD2—Parkinson's disease	0.000196	0.0214	CrCbGaD
Triflupromazine—ABCB1—central nervous system—Parkinson's disease	0.000193	0.00397	CbGeAlD
Triflupromazine—ABCB1—cerebellum—Parkinson's disease	0.000189	0.00388	CbGeAlD
Triflupromazine—Cinacalcet—CYP2D6—Parkinson's disease	0.000163	0.0178	CrCbGaD
Triflupromazine—Clomipramine—GSTP1—Parkinson's disease	0.000159	0.0174	CrCbGaD
Triflupromazine—Acepromazine—DRD1—Parkinson's disease	0.000158	0.0173	CrCbGaD
Triflupromazine—Thioproperazine—DRD1—Parkinson's disease	0.000154	0.0169	CrCbGaD
Triflupromazine—ABCB1—brain—Parkinson's disease	0.000153	0.00315	CbGeAlD
Triflupromazine—Mesoridazine—DRD3—Parkinson's disease	0.000152	0.0167	CrCbGaD
Triflupromazine—Pipotiazine—DRD1—Parkinson's disease	0.000152	0.0166	CrCbGaD
Triflupromazine—Prochlorperazine—DRD3—Parkinson's disease	0.000148	0.0162	CrCbGaD
Triflupromazine—Cyamemazine—HTR2A—Parkinson's disease	0.000134	0.0146	CrCbGaD
Triflupromazine—Fluphenazine—DRD3—Parkinson's disease	0.000133	0.0146	CrCbGaD
Triflupromazine—Fluphenazine—DRD1—Parkinson's disease	0.000131	0.0143	CrCbGaD
Triflupromazine—Acepromazine—HTR1A—Parkinson's disease	0.000131	0.0143	CrCbGaD
Triflupromazine—Thioproperazine—HTR1A—Parkinson's disease	0.000128	0.014	CrCbGaD
Triflupromazine—Propiomazine—DRD1—Parkinson's disease	0.000126	0.0138	CrCbGaD
Triflupromazine—Pipotiazine—HTR1A—Parkinson's disease	0.000126	0.0138	CrCbGaD
Triflupromazine—Mesoridazine—HTR1A—Parkinson's disease	0.000124	0.0136	CrCbGaD
Triflupromazine—Thioridazine—HTR7—Parkinson's disease	0.000122	0.0134	CrCbGaD
Triflupromazine—Chlorprothixene—DRD3—Parkinson's disease	0.000122	0.0133	CrCbGaD
Triflupromazine—Chlorprothixene—DRD1—Parkinson's disease	0.000119	0.0131	CrCbGaD
Triflupromazine—Thioridazine—DRD1—Parkinson's disease	0.000113	0.0124	CrCbGaD
Triflupromazine—Perphenazine—HTR7—Parkinson's disease	0.000112	0.0123	CrCbGaD
Triflupromazine—Acepromazine—DRD2—Parkinson's disease	0.000111	0.0122	CrCbGaD
Triflupromazine—Methotrimeprazine—DRD3—Parkinson's disease	0.00011	0.012	CrCbGaD
Triflupromazine—Fluphenazine—HTR1A—Parkinson's disease	0.000109	0.0119	CrCbGaD
Triflupromazine—Thioproperazine—DRD2—Parkinson's disease	0.000109	0.0119	CrCbGaD
Triflupromazine—Methotrimeprazine—DRD1—Parkinson's disease	0.000108	0.0118	CrCbGaD
Triflupromazine—Pipotiazine—DRD2—Parkinson's disease	0.000107	0.0117	CrCbGaD
Triflupromazine—Mequitazine—CYP2D6—Parkinson's disease	0.000106	0.0116	CrCbGaD
Triflupromazine—Mesoridazine—DRD2—Parkinson's disease	0.000105	0.0115	CrCbGaD
Triflupromazine—Perphenazine—DRD1—Parkinson's disease	0.000104	0.0113	CrCbGaD
Triflupromazine—Prochlorperazine—DRD2—Parkinson's disease	0.000102	0.0112	CrCbGaD
Triflupromazine—Diltiazem—CYP2D6—Parkinson's disease	9.52e-05	0.0104	CrCbGaD
Triflupromazine—Thioridazine—HTR1A—Parkinson's disease	9.38e-05	0.0103	CrCbGaD
Triflupromazine—Promazine—DRD1—Parkinson's disease	9.34e-05	0.0102	CrCbGaD
Triflupromazine—Fluphenazine—DRD2—Parkinson's disease	9.24e-05	0.0101	CrCbGaD
Triflupromazine—Desipramine—SLC6A3—Parkinson's disease	9.14e-05	0.01	CrCbGaD
Triflupromazine—Chlorpromazine—HTR7—Parkinson's disease	8.91e-05	0.00975	CrCbGaD
Triflupromazine—Fluphenazine—CYP2E1—Parkinson's disease	8.89e-05	0.00973	CrCbGaD
Triflupromazine—Propiomazine—DRD2—Parkinson's disease	8.89e-05	0.00973	CrCbGaD
Triflupromazine—Imipramine—HTR7—Parkinson's disease	8.86e-05	0.0097	CrCbGaD
Triflupromazine—Trifluoperazine—HTR1A—Parkinson's disease	8.7e-05	0.00952	CrCbGaD
Triflupromazine—Perphenazine—HTR1A—Parkinson's disease	8.6e-05	0.00942	CrCbGaD
Triflupromazine—Acepromazine—HTR2A—Parkinson's disease	8.59e-05	0.0094	CrCbGaD
Triflupromazine—Chlorprothixene—DRD2—Parkinson's disease	8.41e-05	0.00921	CrCbGaD
Triflupromazine—Thioproperazine—HTR2A—Parkinson's disease	8.4e-05	0.00919	CrCbGaD
Triflupromazine—Chlorpromazine—DRD3—Parkinson's disease	8.37e-05	0.00917	CrCbGaD
Triflupromazine—Pipotiazine—HTR2A—Parkinson's disease	8.26e-05	0.00904	CrCbGaD
Triflupromazine—Chlorpromazine—DRD1—Parkinson's disease	8.22e-05	0.009	CrCbGaD
Triflupromazine—Mesoridazine—HTR2A—Parkinson's disease	8.15e-05	0.00892	CrCbGaD
Triflupromazine—Desipramine—HTR1A—Parkinson's disease	8.01e-05	0.00876	CrCbGaD
Triflupromazine—Thioridazine—DRD2—Parkinson's disease	7.96e-05	0.00871	CrCbGaD
Triflupromazine—Imipramine—SLC6A3—Parkinson's disease	7.75e-05	0.00848	CrCbGaD
Triflupromazine—Thioridazine—CYP2E1—Parkinson's disease	7.66e-05	0.00838	CrCbGaD
Triflupromazine—Methotrimeprazine—DRD2—Parkinson's disease	7.6e-05	0.00832	CrCbGaD
Triflupromazine—Pipotiazine—CYP2D6—Parkinson's disease	7.55e-05	0.00827	CrCbGaD
Triflupromazine—Promethazine—DRD2—Parkinson's disease	7.48e-05	0.00819	CrCbGaD
Triflupromazine—Mesoridazine—CYP2D6—Parkinson's disease	7.45e-05	0.00816	CrCbGaD
Triflupromazine—Trifluoperazine—DRD2—Parkinson's disease	7.38e-05	0.00808	CrCbGaD
Triflupromazine—Methotrimeprazine—CYP2E1—Parkinson's disease	7.31e-05	0.008	CrCbGaD
Triflupromazine—Perphenazine—DRD2—Parkinson's disease	7.3e-05	0.00799	CrCbGaD
Triflupromazine—Prochlorperazine—CYP2D6—Parkinson's disease	7.22e-05	0.0079	CrCbGaD
Triflupromazine—Fluphenazine—HTR2A—Parkinson's disease	7.14e-05	0.00781	CrCbGaD
Triflupromazine—Propiomazine—HTR2A—Parkinson's disease	6.87e-05	0.00752	CrCbGaD
Triflupromazine—Chlorpromazine—HTR1A—Parkinson's disease	6.83e-05	0.00747	CrCbGaD
Triflupromazine—Diltiazem—ABCB1—Parkinson's disease	6.8e-05	0.00744	CrCbGaD
Triflupromazine—Desipramine—DRD2—Parkinson's disease	6.8e-05	0.00744	CrCbGaD
Triflupromazine—Imipramine—HTR1A—Parkinson's disease	6.79e-05	0.00743	CrCbGaD
Triflupromazine—Promazine—DRD2—Parkinson's disease	6.58e-05	0.00721	CrCbGaD
Triflupromazine—Desipramine—CYP2E1—Parkinson's disease	6.54e-05	0.00716	CrCbGaD
Triflupromazine—Clomipramine—HTR2A—Parkinson's disease	6.53e-05	0.00715	CrCbGaD
Triflupromazine—Fluphenazine—CYP2D6—Parkinson's disease	6.53e-05	0.00715	CrCbGaD
Triflupromazine—Chlorprothixene—HTR2A—Parkinson's disease	6.5e-05	0.00711	CrCbGaD
Triflupromazine—Thioridazine—HTR2A—Parkinson's disease	6.15e-05	0.00673	CrCbGaD
Triflupromazine—Clomipramine—CYP2D6—Parkinson's disease	5.97e-05	0.00653	CrCbGaD
Triflupromazine—Methotrimeprazine—HTR2A—Parkinson's disease	5.87e-05	0.00643	CrCbGaD
Triflupromazine—Chlorpromazine—DRD2—Parkinson's disease	5.79e-05	0.00634	CrCbGaD
Triflupromazine—Promethazine—HTR2A—Parkinson's disease	5.78e-05	0.00633	CrCbGaD
Triflupromazine—Imipramine—DRD2—Parkinson's disease	5.77e-05	0.00631	CrCbGaD
Triflupromazine—Trifluoperazine—HTR2A—Parkinson's disease	5.71e-05	0.00625	CrCbGaD
Triflupromazine—Perphenazine—HTR2A—Parkinson's disease	5.64e-05	0.00618	CrCbGaD
Triflupromazine—Thioridazine—CYP2D6—Parkinson's disease	5.62e-05	0.00616	CrCbGaD
Triflupromazine—Chlorpromazine—CYP2E1—Parkinson's disease	5.58e-05	0.0061	CrCbGaD
Triflupromazine—Imipramine—CYP2E1—Parkinson's disease	5.55e-05	0.00607	CrCbGaD
Triflupromazine—Methotrimeprazine—CYP2D6—Parkinson's disease	5.37e-05	0.00588	CrCbGaD
Triflupromazine—Promethazine—CYP2D6—Parkinson's disease	5.29e-05	0.00579	CrCbGaD
Triflupromazine—Desipramine—HTR2A—Parkinson's disease	5.25e-05	0.00575	CrCbGaD
Triflupromazine—Perphenazine—CYP2D6—Parkinson's disease	5.16e-05	0.00565	CrCbGaD
Triflupromazine—Promazine—HTR2A—Parkinson's disease	5.09e-05	0.00557	CrCbGaD
Triflupromazine—Desipramine—CYP2D6—Parkinson's disease	4.8e-05	0.00526	CrCbGaD
Triflupromazine—Fluphenazine—ABCB1—Parkinson's disease	4.66e-05	0.0051	CrCbGaD
Triflupromazine—Chlorpromazine—HTR2A—Parkinson's disease	4.48e-05	0.0049	CrCbGaD
Triflupromazine—Imipramine—HTR2A—Parkinson's disease	4.45e-05	0.00488	CrCbGaD
Triflupromazine—Clomipramine—ABCB1—Parkinson's disease	4.26e-05	0.00467	CrCbGaD
Triflupromazine—Chlorprothixene—ABCB1—Parkinson's disease	4.24e-05	0.00465	CrCbGaD
Triflupromazine—Chlorpromazine—CYP2D6—Parkinson's disease	4.1e-05	0.00448	CrCbGaD
Triflupromazine—Imipramine—CYP2D6—Parkinson's disease	4.07e-05	0.00446	CrCbGaD
Triflupromazine—Promethazine—ABCB1—Parkinson's disease	3.78e-05	0.00413	CrCbGaD
Triflupromazine—Trifluoperazine—ABCB1—Parkinson's disease	3.73e-05	0.00408	CrCbGaD
Triflupromazine—DRD1—Signaling by GPCR—DRD2—Parkinson's disease	3.68e-05	0.000333	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—HTR7—Parkinson's disease	3.68e-05	0.000333	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—HTR2A—Parkinson's disease	3.66e-05	0.000331	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—ADORA2A—Parkinson's disease	3.65e-05	0.00033	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.64e-05	0.000329	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—GRK5—Parkinson's disease	3.63e-05	0.000329	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—HTR1A—Parkinson's disease	3.61e-05	0.000327	CbGpPWpGaD
Triflupromazine—CHRM2—SIDS Susceptibility Pathways—TNF—Parkinson's disease	3.61e-05	0.000326	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—TAC1—Parkinson's disease	3.56e-05	0.000322	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—GRK5—Parkinson's disease	3.56e-05	0.000322	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—NDUFB11—Parkinson's disease	3.55e-05	0.000321	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—HTR1A—Parkinson's disease	3.54e-05	0.00032	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—GFAP—Parkinson's disease	3.52e-05	0.000318	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—GRK5—Parkinson's disease	3.51e-05	0.000318	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—HTR1A—Parkinson's disease	3.49e-05	0.000316	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—DRD1—Parkinson's disease	3.49e-05	0.000316	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—TAC1—Parkinson's disease	3.48e-05	0.000315	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—GRM5—Parkinson's disease	3.48e-05	0.000315	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—TAC1—Parkinson's disease	3.44e-05	0.000311	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—EDN1—Parkinson's disease	3.44e-05	0.000311	CbGpPWpGaD
Triflupromazine—Desipramine—ABCB1—Parkinson's disease	3.43e-05	0.00375	CrCbGaD
Triflupromazine—CHRM1—GPCR downstream signaling—DRD1—Parkinson's disease	3.41e-05	0.000309	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GCH1—Parkinson's disease	3.39e-05	0.000306	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—DRD3—Parkinson's disease	3.38e-05	0.000306	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—DRD1—Parkinson's disease	3.37e-05	0.000305	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—DRD3—Parkinson's disease	3.31e-05	0.000299	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—HTR1A—Parkinson's disease	3.28e-05	0.000297	CbGpPWpGaD
Triflupromazine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	3.27e-05	0.000296	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—DRD3—Parkinson's disease	3.26e-05	0.000295	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—GRM4—Parkinson's disease	3.26e-05	0.000295	CbGpPWpGaD
Triflupromazine—DRD1—Circadian rythm related genes—IL6—Parkinson's disease	3.26e-05	0.000295	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—EDN1—Parkinson's disease	3.24e-05	0.000293	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—FGF20—Parkinson's disease	3.23e-05	0.000293	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—TAC1—Parkinson's disease	3.23e-05	0.000292	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—HTR1A—Parkinson's disease	3.21e-05	0.000291	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—GRM4—Parkinson's disease	3.19e-05	0.000289	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—HTR1A—Parkinson's disease	3.17e-05	0.000287	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—DRD1—Parkinson's disease	3.17e-05	0.000287	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—TAC1—Parkinson's disease	3.16e-05	0.000286	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—ADRBK1—Parkinson's disease	3.16e-05	0.000285	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—GRM4—Parkinson's disease	3.15e-05	0.000285	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—ADORA2A—Parkinson's disease	3.14e-05	0.000284	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—TAC1—Parkinson's disease	3.12e-05	0.000282	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—EDN1—Parkinson's disease	3.12e-05	0.000282	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—DRD1—Parkinson's disease	3.1e-05	0.000281	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PENK—Parkinson's disease	3.09e-05	0.00028	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MAG—Parkinson's disease	3.09e-05	0.00028	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—ADRBK1—Parkinson's disease	3.09e-05	0.000279	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—DRD3—Parkinson's disease	3.07e-05	0.000278	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—DRD1—Parkinson's disease	3.06e-05	0.000277	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—HTR7—Parkinson's disease	3.06e-05	0.000277	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—FGF20—Parkinson's disease	3.05e-05	0.000276	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—ADRBK1—Parkinson's disease	3.05e-05	0.000276	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PENK—Parkinson's disease	3.02e-05	0.000274	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MAG—Parkinson's disease	3.02e-05	0.000274	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GBA—Parkinson's disease	3.02e-05	0.000273	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—FBP1—Parkinson's disease	3.02e-05	0.000273	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—DBH—Parkinson's disease	3.02e-05	0.000273	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—HTR2A—Parkinson's disease	3.01e-05	0.000272	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—DRD3—Parkinson's disease	3e-05	0.000272	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—HTR7—Parkinson's disease	2.99e-05	0.000271	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—DRD2—Parkinson's disease	2.99e-05	0.000271	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PENK—Parkinson's disease	2.98e-05	0.00027	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MAG—Parkinson's disease	2.98e-05	0.00027	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—DRD3—Parkinson's disease	2.96e-05	0.000268	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—ADORA2A—Parkinson's disease	2.96e-05	0.000268	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—HTR7—Parkinson's disease	2.95e-05	0.000267	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—DRD2—Parkinson's disease	2.95e-05	0.000267	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—EDN1—Parkinson's disease	2.94e-05	0.000266	CbGpPWpGaD
Triflupromazine—Chlorpromazine—ABCB1—Parkinson's disease	2.92e-05	0.0032	CrCbGaD
Triflupromazine—CHRM2—SIDS Susceptibility Pathways—IL6—Parkinson's disease	2.91e-05	0.000263	CbGpPWpGaD
Triflupromazine—Imipramine—ABCB1—Parkinson's disease	2.91e-05	0.00318	CrCbGaD
Triflupromazine—HTR2B—Signaling Pathways—INSR—Parkinson's disease	2.89e-05	0.000262	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—ADRBK1—Parkinson's disease	2.87e-05	0.000259	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—CYP2D6—Parkinson's disease	2.84e-05	0.000257	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—HTR2A—Parkinson's disease	2.83e-05	0.000256	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PDYN—Parkinson's disease	2.83e-05	0.000256	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—ADRBK1—Parkinson's disease	2.8e-05	0.000254	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—CTGF—Parkinson's disease	2.79e-05	0.000252	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—HTR7—Parkinson's disease	2.78e-05	0.000251	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—ADRBK1—Parkinson's disease	2.77e-05	0.00025	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PDYN—Parkinson's disease	2.77e-05	0.00025	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—FGB—Parkinson's disease	2.74e-05	0.000248	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—INSR—Parkinson's disease	2.73e-05	0.000247	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—HTR2A—Parkinson's disease	2.73e-05	0.000247	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PDYN—Parkinson's disease	2.73e-05	0.000247	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—HTR1A—Parkinson's disease	2.72e-05	0.000246	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—DRD2—Parkinson's disease	2.72e-05	0.000246	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—HTR7—Parkinson's disease	2.72e-05	0.000246	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	2.7e-05	0.000245	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of proteins—INS—Parkinson's disease	2.68e-05	0.000243	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—HTR7—Parkinson's disease	2.68e-05	0.000243	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—DRD2—Parkinson's disease	2.68e-05	0.000243	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TAC1—Parkinson's disease	2.68e-05	0.000243	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—GFAP—Parkinson's disease	2.66e-05	0.00024	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	2.64e-05	0.000239	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—DRD1—Parkinson's disease	2.63e-05	0.000238	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—GRM5—Parkinson's disease	2.63e-05	0.000238	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—GFAP—Parkinson's disease	2.6e-05	0.000235	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—CYP2E1—Parkinson's disease	2.6e-05	0.000235	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—FGB—Parkinson's disease	2.58e-05	0.000233	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—HTR2A—Parkinson's disease	2.57e-05	0.000233	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—GRM5—Parkinson's disease	2.57e-05	0.000233	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—NQO1—Parkinson's disease	2.57e-05	0.000232	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—HTR1A—Parkinson's disease	2.57e-05	0.000232	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—GFAP—Parkinson's disease	2.57e-05	0.000232	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—DRD3—Parkinson's disease	2.55e-05	0.00023	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—GRM5—Parkinson's disease	2.54e-05	0.00023	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	2.53e-05	0.000229	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—TH—Parkinson's disease	2.53e-05	0.000229	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TAC1—Parkinson's disease	2.53e-05	0.000229	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	2.48e-05	0.000225	CbGpPWpGaD
Triflupromazine—DRD2—Circadian rythm related genes—IL6—Parkinson's disease	2.46e-05	0.000223	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—EDN1—Parkinson's disease	2.45e-05	0.000221	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—CYCS—Parkinson's disease	2.43e-05	0.00022	CbGpPWpGaD
Triflupromazine—CHRM1—Circadian rythm related genes—IL6—Parkinson's disease	2.41e-05	0.000218	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—DRD3—Parkinson's disease	2.4e-05	0.000217	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—EDN1—Parkinson's disease	2.39e-05	0.000217	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—ADRBK1—Parkinson's disease	2.38e-05	0.000215	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—EDN1—Parkinson's disease	2.36e-05	0.000214	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—FGF20—Parkinson's disease	2.3e-05	0.000208	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—DRD2—Parkinson's disease	2.3e-05	0.000208	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—HTR7—Parkinson's disease	2.3e-05	0.000208	CbGpPWpGaD
Triflupromazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	2.28e-05	0.000206	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—FGF20—Parkinson's disease	2.25e-05	0.000204	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—ADRBK1—Parkinson's disease	2.24e-05	0.000203	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ADORA2A—Parkinson's disease	2.23e-05	0.000202	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—FGF20—Parkinson's disease	2.23e-05	0.000201	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—EDN1—Parkinson's disease	2.22e-05	0.000201	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—DDC—Parkinson's disease	2.21e-05	0.0002	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.2e-05	0.000199	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ADORA2A—Parkinson's disease	2.19e-05	0.000198	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—EDN1—Parkinson's disease	2.17e-05	0.000197	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—HTR7—Parkinson's disease	2.17e-05	0.000196	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—DRD2—Parkinson's disease	2.17e-05	0.000196	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ADORA2A—Parkinson's disease	2.16e-05	0.000195	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—COMT—Parkinson's disease	2.15e-05	0.000195	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—EDN1—Parkinson's disease	2.15e-05	0.000194	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—GSTP1—Parkinson's disease	2.14e-05	0.000194	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—HTR2A—Parkinson's disease	2.14e-05	0.000194	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—MAOA—Parkinson's disease	2.14e-05	0.000193	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—HMOX1—Parkinson's disease	2.11e-05	0.000191	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	2.09e-05	0.00019	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GSTA4—Parkinson's disease	2.09e-05	0.000189	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—HTR2A—Parkinson's disease	2.07e-05	0.000187	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—INSR—Parkinson's disease	2.06e-05	0.000187	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—ABCB1—Parkinson's disease	2.03e-05	0.000183	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—INSR—Parkinson's disease	2.02e-05	0.000183	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—INSR—Parkinson's disease	1.99e-05	0.00018	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—GSTM1—Parkinson's disease	1.97e-05	0.000178	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	1.97e-05	0.000178	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—FGB—Parkinson's disease	1.95e-05	0.000176	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—HTR2A—Parkinson's disease	1.94e-05	0.000176	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—HTR1A—Parkinson's disease	1.94e-05	0.000175	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IGF2—Parkinson's disease	1.93e-05	0.000175	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TAC1—Parkinson's disease	1.91e-05	0.000173	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—FGB—Parkinson's disease	1.91e-05	0.000173	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—HTR2A—Parkinson's disease	1.9e-05	0.000172	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—HTR1A—Parkinson's disease	1.9e-05	0.000172	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—GPX1—Parkinson's disease	1.88e-05	0.000171	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PLA2G6—Parkinson's disease	1.88e-05	0.00017	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—FGB—Parkinson's disease	1.88e-05	0.00017	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—HTR2A—Parkinson's disease	1.88e-05	0.00017	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—HTR1A—Parkinson's disease	1.87e-05	0.000169	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—DRD1—Parkinson's disease	1.87e-05	0.000169	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TAC1—Parkinson's disease	1.87e-05	0.000169	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IGF1R—Parkinson's disease	1.87e-05	0.000169	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—MAOB—Parkinson's disease	1.86e-05	0.000169	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TAC1—Parkinson's disease	1.84e-05	0.000167	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—EDN1—Parkinson's disease	1.84e-05	0.000167	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—DRD1—Parkinson's disease	1.83e-05	0.000166	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IGF2—Parkinson's disease	1.82e-05	0.000165	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—DRD3—Parkinson's disease	1.81e-05	0.000164	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—DRD1—Parkinson's disease	1.81e-05	0.000164	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—DRD3—Parkinson's disease	1.77e-05	0.000161	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IGF1R—Parkinson's disease	1.76e-05	0.000159	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—DRD3—Parkinson's disease	1.75e-05	0.000158	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—MTHFR—Parkinson's disease	1.74e-05	0.000157	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—EDN1—Parkinson's disease	1.74e-05	0.000157	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—NGF—Parkinson's disease	1.69e-05	0.000153	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ADRBK1—Parkinson's disease	1.69e-05	0.000153	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ADRBK1—Parkinson's disease	1.66e-05	0.00015	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—HTR7—Parkinson's disease	1.64e-05	0.000148	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ADRBK1—Parkinson's disease	1.64e-05	0.000148	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—APOE—Parkinson's disease	1.62e-05	0.000147	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—HTR2A—Parkinson's disease	1.61e-05	0.000146	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—HTR7—Parkinson's disease	1.6e-05	0.000145	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—DRD2—Parkinson's disease	1.6e-05	0.000145	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—NGF—Parkinson's disease	1.6e-05	0.000145	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—HTR7—Parkinson's disease	1.58e-05	0.000143	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—DRD2—Parkinson's disease	1.58e-05	0.000143	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—HTR2A—Parkinson's disease	1.52e-05	0.000138	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—APOE—Parkinson's disease	1.5e-05	0.000136	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—APOE—Parkinson's disease	1.41e-05	0.000128	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CYP2D6—Parkinson's disease	1.39e-05	0.000125	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—INS—Parkinson's disease	1.38e-05	0.000125	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IGF2—Parkinson's disease	1.37e-05	0.000124	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CTGF—Parkinson's disease	1.36e-05	0.000123	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	1.34e-05	0.000122	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	1.33e-05	0.00012	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	1.33e-05	0.00012	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—EDN1—Parkinson's disease	1.31e-05	0.000119	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	1.3e-05	0.000118	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	1.28e-05	0.000116	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	1.28e-05	0.000116	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—INS—Parkinson's disease	1.28e-05	0.000116	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	1.27e-05	0.000115	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CYP2E1—Parkinson's disease	1.27e-05	0.000115	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—NQO1—Parkinson's disease	1.25e-05	0.000113	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—TH—Parkinson's disease	1.23e-05	0.000112	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—INS—Parkinson's disease	1.21e-05	0.000109	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NGF—Parkinson's disease	1.21e-05	0.000109	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CYCS—Parkinson's disease	1.19e-05	0.000107	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NGF—Parkinson's disease	1.18e-05	0.000107	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NGF—Parkinson's disease	1.17e-05	0.000105	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	1.15e-05	0.000104	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	1.12e-05	0.000102	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	1.11e-05	0.0001	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—APOE—Parkinson's disease	1.07e-05	9.66e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—COMT—Parkinson's disease	1.05e-05	9.5e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GSTP1—Parkinson's disease	1.05e-05	9.46e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—APOE—Parkinson's disease	1.04e-05	9.45e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—MAOA—Parkinson's disease	1.04e-05	9.43e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—APOE—Parkinson's disease	1.03e-05	9.33e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—HMOX1—Parkinson's disease	1.03e-05	9.33e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GSTM1—Parkinson's disease	9.6e-06	8.69e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CASP3—Parkinson's disease	9.54e-06	8.63e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—IL6—Parkinson's disease	9.47e-06	8.57e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GPX1—Parkinson's disease	9.2e-06	8.32e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—INS—Parkinson's disease	9.12e-06	8.25e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CASP3—Parkinson's disease	8.99e-06	8.14e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—IL6—Parkinson's disease	8.93e-06	8.08e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—INS—Parkinson's disease	8.92e-06	8.07e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—INS—Parkinson's disease	8.81e-06	7.97e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MAPK8—Parkinson's disease	8.76e-06	7.93e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—MTHFR—Parkinson's disease	8.49e-06	7.68e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MAPK8—Parkinson's disease	8.26e-06	7.48e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—APOE—Parkinson's disease	7.9e-06	7.15e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CASP3—Parkinson's disease	6.79e-06	6.14e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—INS—Parkinson's disease	6.75e-06	6.11e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—IL6—Parkinson's disease	6.75e-06	6.1e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	6.64e-06	6.01e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	6.6e-06	5.97e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	6.56e-06	5.93e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	6.52e-06	5.9e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	6.24e-06	5.65e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	6.11e-06	5.53e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	6.03e-06	5.45e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IL6—Parkinson's disease	5.6e-06	5.06e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IL6—Parkinson's disease	5.28e-06	4.78e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IL6—Parkinson's disease	3.98e-06	3.61e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IL6—Parkinson's disease	3.9e-06	3.53e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IL6—Parkinson's disease	3.85e-06	3.48e-05	CbGpPWpGaD
